A recent study has uncovered significant connections between eating disorders (EDs), including anorexia nervosa (AN), and neurodevelopmental disorders such as attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The findings highlight both genetic and environmental factors contributing to these associations, with a potential path for targeted interventions. The findings were published in the journal Molecular Psychiatry.

The research, based on a Danish population cohort of over 1.6 million individuals born between 1981 and 2008, utilised registry data to explore patterns of diagnosis, family relationships, and genetic predispositions. The study established that individuals with ADHD or ASD were more likely to develop eating disorders and vice versa. Key to these findings was the role of mood and anxiety disorders, which were shown to mediate up to 100% of the association between neurodevelopmental conditions and EDs.

The study also examined genetic data to uncover underlying links. For instance, a positive correlation was observed between ASD-related genetic markers and AN risk, whereas ADHD-related genetic markers appeared inversely associated with AN. Such findings suggest that shared genetic architecture may partly explain the co-occurrence of these disorders.

Familial patterns also provided compelling insights. Individuals with siblings diagnosed with ADHD or ASD showed a heightened risk of developing EDs themselves, with maternal half-siblings of those with ASD showing an increased likelihood of AN. This underscores the interplay of genetic and shared environmental factors in these associations.

Interestingly, the research pointed out differences in the way ADHD and ASD are linked to specific eating disorder subtypes. ADHD appeared more closely associated with bulimia nervosa and binge-eating behaviours, while ASD was linked with restrictive eating patterns, often seen in conditions like avoidant/restrictive food intake disorder (ARFID).

The implications of these findings are profound for clinical practice. By recognising the overlapping risks and the pivotal role of mood and anxiety disorders, early intervention strategies can be developed to address emerging symptoms in at-risk individuals. This could involve more comprehensive screening processes for co-occurring conditions in those presenting with either neurodevelopmental disorders or eating disorders.

The study highlights the complexity of these interrelated conditions and the need for further research to unravel the specific mechanisms driving their association. Such work will be critical in refining treatment approaches and improving outcomes for affected individuals.